| 2/2/2021 |
Intern - Product Development - Personalized Healthcare Informatics : South San Francisco |
gene.com |
Intern - Product Development - Personalized Healthcare Informatics South San Francisco, CaliforniaStart Date: May 25, 2021 ( Summer 2021)Work Hours: 40 hours per weekLength of Assignment: 3 MonthsEducation Level: Bachelor's (must be enrolled in or completed their 2nd year)Preferred Majors/Disciplines: P ursuing degree in Data Science, Computer Science, Information Science, or equivalentGiven the current uncertainty of the global pandemic and work from home situation for 2021 ... |
| 2/2/2021 |
Intern - Product Development - Personalized Healthcare Data Science Imaging : South San Francisco |
gene.com |
Intern - Product Development - Personalized Healthcare Data Science Imaging South San Francisco, CaliforniaStart Date: May 18, 2021 ( Summer 2021)Work Hours: 40 hours per weekLength of Assignment: 3 MonthsEducation Level: Master's, PhDPreferred Majors/Disciplines: An applied quantitative discipline such as Computer Science, Electronic Engineering, Bioengineering, Statistics, Mathematics, Operations ResearchGiven the current uncertainty of the global pandemic and work from home situation for 2021, this internship is ... |
| 2/2/2021 |
Intern - Pharma Informatics - Personalized Healthcare Informatics : South San Francisco |
gene.com |
Intern - Pharma Informatics - Personalized Healthcare Informatics South San Francisco, CaliforniaStart Date: May 25, 2021 ( Summer 2021)Work Hours: 40 hours per weekLength of Assignment: 3 MonthsEducation Level: Bachelor's (must be enrolled in or completed their 2nd year)Preferred Majors/Disciplines: P ursuing degree in Data Science, Computer Science, Information Science, or equivalentGiven the current uncertainty of the global pandemic and work from home situation for 2021 ... |
| 2/1/2021 |
Progressive Care Completes Expansion, Launches COVID-19 Rapid Testing at New Orlando Location Other OTC:RXMD |
Globe Newswire |
MIAMI, FL, via NewMediaWire – Progressive Care Inc. (OTCQB:RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is excited to announce that its new 3,700 square foot Orlando pharmacy has now officially opened for business as a potent full-service location that is also expected to act as a growth hub for rapid results viral testing services, Covid-19 vaccinations, and 340B third ... |
| 2/1/2021 |
MIAMI, FL, Feb. 01, 2021 (GLOBE NEWSWIRE) -- via N |
wapakdailynews.com |
MIAMI, FL, via NewMediaWire – Progressive Care Inc. ( OTCQB:RXMD ) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is excited to announce that its new 3,700 square foot Orlando pharmacy has now officially opened for business as a potent full-service location that is also expected to act as a growth hub for rapid results viral testing services, Covid-19 vaccinations, and 340B third ... |
| 2/1/2021 |
Progressive Care Completes Expansion, Launches COVID-19 Rapid Testing at New Orlando Location |
otcmarkets.com |
MIAMI, FL, Feb. 01, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Progressive Care Inc. (OTCQB:RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is excited to announce that its new 3,700 square foot Orlando pharmacy has now officially opened for business as a potent full-service location that is also expected to act as a growth hub for rapid results viral testing services, Covid ... |
| 1/31/2021 |
Zacks Investment Research Upgrades NantHealth (NASDAQ:NH) to Buy |
Daily Political |
... a $4.50 target price on the stock. Zacks Investment Research ‘s target price would indicate a potential upside of 6.64% from the company’s current price.According to Zacks, “Nant Health, LLC is a personalized healthcare company which enable improved patient outcomes and treatment decisions for critical illnesses. The company developed an adaptive learning system, CLINICS, which includes its unique software, middleware and hardware systems infrastructure that collects, indexes, analyzes ... |
| 1/28/2021 |
Intern - Roche Advanced Analytics Network - Personalized Healthcare : South San Francisco |
gene.com |
Intern - Roche Advanced Analytics Network - Personalized HealthcareStart Date: May 25, 2021 ( Summer 2021)Work Hours: 40 hours per weekLength of Assignment: 3 monthsEducation Level: Masters or Ph.D. studentPreferred Majors/Disciplines: Biomedical Engineering/CS/Bioinformatics/Statistics or related quantitative sciencesGiven the current uncertainty of the global pandemic and work from home situation for 2021, this internship is currently planned to be virtual with the option for ... |
| 1/27/2021 |
Intern - Advanced Analytics Network - Personalized Health Care: Data Science Imaging : South San Francisco |
gene.com |
... innovative tools requires fundamental changes in how we develop and deliver diagnostics and treatments.Job Description/ResponsibilitiesWe are seeking a highly qualified and self-motivated intern to join our neuroscience efforts in the Personalized Healthcare Data Science Imaging group at Roche/Genentech, with the goal to develop novel machine learning/deep learning (ML/DL) methods in order to gain insights from our large scale clinical imaging datasets. The ideal ... |
| 1/26/2021 |
Blood Glucose Testing Devices Market Trends, Regulations and Competitive Landscape Outlook to 2026 |
financialplanning24.com |
Blood Glucose Testing Devices Market : Insights Blood glucose testing devices are used to monitor and analyze blood glucose levels in various healthcare settings and are becoming an integral part of personalized healthcare monitoring. Diabetes affects worldwide and Diabetics patient have to check blood sugar several times in a day. Usually patient or nurse pricking finger for the test. Blood glucose testing devices is easy to handle, easy to carry and ... |
| 1/18/2021 |
NantHealth (NASDAQ:NH) Lifted to “Buy” at Zacks Investment Research |
Daily Political |
upgraded shares of NantHealth (NASDAQ:NH) from a hold rating to a buy rating in a report published on Thursday, Zacks.com reports. The firm currently has $4.00 target price on the stock. According to Zacks, “Nant Health, LLC is a personalized healthcare company which enable improved patient outcomes and treatment decisions for critical illnesses. The company developed an adaptive learning system, CLINICS, which includes its unique software, middleware and hardware ... |
| 1/18/2021 |
NantHealth (NASDAQ:NH) Rating Increased to Buy at Zacks Investment Research |
slatersentinel.com |
... hold rating to a buy rating in a research note issued to investors on Thursday, Zacks.com reports. They currently have $4.00 price objective on the stock.According to Zacks, “Nant Health, LLC is a personalized healthcare company which enable improved patient outcomes and treatment decisions for critical illnesses. The company developed an adaptive learning system, CLINICS, which includes its unique software, middleware and hardware systems infrastructure that collects, indexes, analyzes ... |
| 1/17/2021 |
NantHealth (NASDAQ:NH) Raised to “Buy” at Zacks Investment Research |
zolmax.com |
... from a hold rating to a buy rating in a research note released on Thursday, Zacks.com reports. They currently have $4.00 price target on the stock.According to Zacks, “Nant Health, LLC is a personalized healthcare company which enable improved patient outcomes and treatment decisions for critical illnesses. The company developed an adaptive learning system, CLINICS, which includes its unique software, middleware and hardware systems infrastructure that collects, indexes, analyzes ... |
| 1/17/2021 |
NantHealth (NASDAQ:NH) Lifted to “Buy” at Zacks Investment Research |
Daily Political |
... hold rating to a buy rating in a research note issued to investors on Thursday, Zacks.com reports. They currently have $4.00 price objective on the stock.According to Zacks, “Nant Health, LLC is a personalized healthcare company which enable improved patient outcomes and treatment decisions for critical illnesses. The company developed an adaptive learning system, CLINICS, which includes its unique software, middleware and hardware systems infrastructure that collects, indexes, analyzes ... |
| 1/17/2021 |
Health Coverage Should Flex in Real Time with Your Personal Health Needs |
medicalalley.org |
Tags: Bind Benefits , COVID-19 , Featured , Health Coverage , Health Insurance , Medical Alley , Member , Personalized Healthcare , Sponsored , Tony MillerHow did you use health care in 2019? (I would ask about 2020, but Covid-19 has thrown everyone off.) Think about how many times you sought care, and what medical treatments you received. Got a rough idea? Was it the same as in 2018? The same number of visits, for the ... |
| 1/15/2021 |
Bioinformatics Scientist, OMNI Biomarker Development : South San Francisco |
gene.com |
... biomarker teams to analyze multi-level biomarker data generated from pre-clinical experiments, clinical trials, and/or real-world clinical studies. This work will advance understanding of disease heterogeneity, and generate insights that advance personalized healthcare by identifying “the right drug for the right patient at the right dose”. The candidate will work closely with the Bioinformatics and Computational Biology Department in Research.ResponsibilitiesThe successful candidate will join ... |
| 1/14/2021 |
Global Home Health Monitoring Device Market Report 2020-2025 with Analysis of Leading Manufacturers of Home Health Monitoring Devices |
PR Newswire |
... day communications. Doctors, patients, or caregivers are very comfortable in using and operating these systems, and this is the unique selling point for home-based healthcare devices.The publisher sees this ability to provide personalized healthcare services as becoming a key selling point for home health monitoring devices. The emerging applications such as continuous glucose monitoring or continuous heart rate monitoring have helped doctors and patients understand the health patterns ... |
| 1/14/2021 |
NantHealth (NASDAQ:NH) Upgraded to “Buy” by Zacks Investment Research |
rivertonroll.com |
... a $4.00 target price on the stock. Zacks Investment Research ‘s target price points to a potential upside of 17.99% from the stock’s current price.According to Zacks, “Nant Health, LLC is a personalized healthcare company which enable improved patient outcomes and treatment decisions for critical illnesses. The company developed an adaptive learning system, CLINICS, which includes its unique software, middleware and hardware systems infrastructure that collects, indexes, analyzes ... |
| 1/14/2021 |
Nayya Raises $11M Series A Led By Felicis Ventures to Optimize Personalized Healthcare Decisions |
vcaonline.com |
Nayya Raises $11M Series A Led By Felicis Ventures to Optimize Personalized Healthcare Decisions Funding to Support Enterprise Adoption of Nayya's Next-Generation Personalized Benefits Platform NEW YORK, January 14, 2021-- Nayya, the leading insurance benefits experience and management platform, today announced that it has closed $11M in Series A funding led by Felicis Ventures, with continued support from all early investors including Social Leverage, Guardian Life, one of the ... |
| 1/14/2021 |
Nayya Raises $11M Series A Led By Felicis Ventures to Optimize Personalized Healthcare Decisions |
tmcnet.com |
Nayya Raises $11M Series A Led By Felicis Ventures to Optimize Personalized Healthcare Decisions [January 14, 2021] Nayya Raises $11M Series A Led By Felicis Ventures to Optimize Personalized Healthcare DecisionsNEW YORK , Jan. 14, 2021 /PRNewswire/ -- Nayya, the leading insurance benefits experience and management platform, today announced that it has closed $11M in Series A funding led by Felicis Ventures, with continued support from all early investors including Social ... |